Legal Opinion from Shanghai Jintiancheng Law Firm
Address:
501 Yincheng Middle Road, Shanghai Tower, 9/11/12 Floors, Pudong New District, Shanghai
Phone:
021-20511000
Fax:
021-20511999
Postal Code:
200120
To:
Zhejiang Jingxin Pharmaceutical Co., Ltd.
Shanghai Jintiancheng Law Firm (hereinafter referred to as "this Firm") has been entrusted by Zhejiang Jingxin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "Jingxin Pharmaceutical") to provide legal opinions regarding the Company's first extraordinary shareholders' meeting in 2026 (hereinafter referred to as "this Shareholders' Meeting"). This opinion is issued in accordance with the Company Law of the People's Republic of China (hereinafter referred to as "the Company Law"), the Rules for Shareholders' Meetings of Listed Companies, and other relevant laws, regulations, and normative documents, as well as the Articles of Association of Zhejiang Jingxin Pharmaceutical Co., Ltd. (hereinafter referred to as "the Articles of Association").
To issue this legal opinion, this Firm and its lawyers have strictly fulfilled their statutory duties in accordance with the Management Measures for Securities Legal Business of Law Firms and the Practice Rules for Securities Legal Business of Law Firms (Trial), adhering to the principles of diligence and good faith. Necessary verifications and validations of the relevant matters concerning this Shareholders' Meeting have been conducted, and the relevant documents and materials deemed necessary for issuing this legal opinion have been reviewed. The lawyers of this Firm participated in the entire process of this Shareholders' Meeting. This Firm guarantees that the facts recognized in this legal opinion are true, accurate, and complete, and that the conclusions drawn are legal and accurate, with no false records, misleading statements, or significant omissions, and is willing to bear corresponding legal responsibilities.
Legal Opinions:
- Qualifications of the Convener and Procedures for Convening and Holding the Meeting
(1) The convener of this Shareholders' Meeting has been verified, and it is confirmed that the meeting was convened by the Company's Board of Directors. On January 12, 2026, the Company held the third meeting of the ninth Board of Directors, which resolved to convene this Shareholders' Meeting.
The Company published the "Notice of the First Extraordinary Shareholders' Meeting of Jingxin Pharmaceutical in 2026" on January 13, 2026, on the Giant Tide Information Network (http://www.cninfo.com.cn). The notice specified the convener, date and time of the meeting (including the date and time of the on-site meeting and the date and time for online voting), method of convening, equity registration date, attendees, meeting location, matters for deliberation, registration methods for the on-site meeting, specific procedures for participating in online voting, and contact information. The date of the announcement was 15 days prior to the date of the Shareholders' Meeting.
(2) The on-site meeting of this Shareholders' Meeting was held as scheduled on January 28, 2026, at 14:00 in the conference room on the first floor of the Company's administrative building located at 800 East Xinchang Avenue, Yulin Street, Xinchang County, Zhejiang Province. The meeting was conducted using a combination of on-site voting and online voting. The specific time for online voting through the Shenzhen Stock Exchange trading system was from 9:15 to 9:25, 9:30 to 11:30, and 13:00 to 15:00 on January 28, 2026; the specific time for online voting through the Shenzhen Stock Exchange Internet voting system was from 9:15 to 15:00 on January 28, 2026. After review, this Firm's lawyers believe that the qualifications of the convener of this Shareholders' Meeting are legal and valid, and the procedures for convening and holding the meeting comply with the Company Law, the Rules for Shareholders' Meetings of Listed Companies, and other relevant laws, regulations, and normative documents, as well as the Articles of Association.